CompletedPHASE2, PHASE3NCT03479476

A Trial of Metformin in Individuals With Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, Davis
Principal Investigator
Randi J Hagerman, MD
University of California, Davis
Intervention
Placebo Medication(drug)
Enrollment
120 enrolled
Eligibility
6-25 years · All sexes
Timeline
20182024

Study locations (3)

Collaborators

University of Alberta · St. Justine's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03479476 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials